Skip to main content
. 2021 Mar 1;11:4863. doi: 10.1038/s41598-021-83831-8

Table 5.

Characteristics of patients according to the outcome.

Discharged Deceased (N = 5), Median (range) p value discharged vs deceased1 p value discharged with vs without ICU admission1
All (N = 56) With ICU admission (N = 5) Without ICU admission (N = 51)
Median (range) Median (range) Median (range)
Age 63.50 (32–93) 69 (58–78) 62 (32–93) 78 (65–91) 0.039 ns
Days of symptoms before CT 5 (1–16) 4 (1–9) 6 (1–16) 5 (1–7) ns ns
WBC (N × 103/μL) 5.18 (2.33–13.14) 6.06 (4.65–13.14) 5.07 (2.33–12.97) 11.78 (4.84–12.45) 0.023 ns
ANC (N × 103/μL) 3.37 (1.17–11.04) 4.30 (2.93–10.16) 3.32 (1.17–11.04) 10.16 (3.70–11.15) 0.005 ns
ALC (N × 103/μL) 1.07 (0.48–2.49) 1.27 (0.48–2.14) 1.07 (0.48–2.49) 0.83 (0.55–1.17) ns ns
AMC (N × 103/μL) 0.380 (0.13–1.33) 0.81 (0.20–1.33) 0.38 (0.13–0.82) 0.30 (0.24–1.06) ns ns
N:L ratio 3.28 (0.89–21.16) 4.32 (2.45–21.16) 3.21 (0.89–16.71) 9.29 (4.30–18.47) 0.004 ns
Hb (g/L) 13.30 (9.70–16.70) 13.20 (11.40–16.0) 13.3 (9.70–16.70) 12.10 (8.8–17.7) ns ns
PLTs 203 (92–444) 187.50 (167–314) 203 (92–444) 261 (125–373) ns ns
ESR (mm/h) 67 (2–116) 48 (30–67) 67 (2–116) 86 (44–94) ns ns
CRP (mg/dl) 3.55 (0.03–17.30) 5.10 (3.55–13.98) 2.99 (0.03–17.30) 9.03 (3.55–18.80) ns ns
Ferritin 539.75 (23.4–5031.60) 796 (530.50–1750.10) 473.50 (23.40–5031.60) 629.30 (213.20–876.20) ns ns
Ferritin:ESR ratio 7.79 (0.3–213.2) 12.30 (7.9–53.9) 7.28 (0.30–213.20) 47. 39 (6.70–88.10) ns ns
D-dimer 0.91 (0.27–18.30) 1.94 (0.99–11.88) 0.85 (0.27–18.30) 1.48 (0.65–4.00) ns 0.037
Fibrinogen 552 (228–1021) 552 (458–767) 542 (228–1021) 595.50 (498–627) ns ns
LDH 297 (96–534) 362 (301–534) 277.50 (96–514) 732 (379–998) 0.009 0.044
procalcitonin 0.086 (0.02–1.31) 0.33 (0.04–0.57) 0.08 (0.02–1.31) 0.66 (0.10–1.97) 0.015 ns
PaO2/FiO2 313 (95–523) 196 (122–278) 320.50 (95–523) 223 (133–280) 0.008 0.002
Severity score A 6 (1–11) 10 (2–11) 6 (1–10) 8 (2–13) ns 0.022
Severity score B 6 (1–13) 12 (2–13) 6 (1–12) 10 (2–18) ns 0.033
Discharged Deceased (N = 5), N (%) p value discharged vs deceased2 p value discharged with vs without ICU admission2
All (N = 56) With ICU admission (N = 5) Without ICU admission (N = 51)
N (%) N (%) N (%)
Gender ns ns
F 20 (36) 0 (0) 20 (39) 2 (40)
M 36 (64) 5 (100) 31 (61) 3 (60)
Age over 65 years 26 (46) 4 (80) 22 (43) 5 (100) ns ns
No. of lobes affected ns ns
1 2 (4) 0 (0) 2 (4) 0 (0)
2 6 (11) 1 (20) 5 (10) 1 (20)
3 7 (13) 0 (0) 7 (14) 0 (0)
4 7 (13) 1 (20) 6 (12) 2 (40)
5 34 (61) 3 (60) 31 (61) 2 (40)
Bilateral lung disease 53 (95) 5 (100) 48 (94) 5 (100) ns ns
Type of parenchymal lesions
Neither ground glass opacities nor consolidation 0 (0) 0 (0) 0 (0) 0 (0)
Ground glass opacities only 31 (55) 2 (40) 29 (57) 1 (20)
Consolidation only 0 (0) 0 (0) 0 (0) 0 (0)
Ground glass opacities and consolidation 25 (45) 3 (60) 22 (43) 4 (80)
Septal thickening 41 (73) 4 (80) 37 (73) 5 (100) ns ns
Pleural effusion 9 (16) 1 (20) 8 (16) 2 (40) ns ns
Mediastinal lymph node enlargement 18 (32) 1 (20) 17 (33) 2 (40) ns ns

CT computer tomography, ICU intensive care unit, SD standard deviation, WBC white blood cells, ANC absolute neutrophil count, ALC absolute lymphocyte count, AMC absolute monocyte count, N:L neutrophils:lymphocytes, Hb haemoglobin, PLT platelets, ESR erythrocyte sedimentation rate, CRP C reactive protein, LDH lactate dehydrogenase, M male, F female.

1p value calculated wiith Mann Whitney U test.

2p value calculated with the χ2 test or the Fisher's exact test as needed.